false

Teresa Pokladowski

Teresa is a respected business development strategist, building successful clinical programs for clients in Massachusetts. She is an innovator of fresh approaches to biomarker planning, translational solutions, and clinical study design. Her experience spans the execution of Phase 1-4 clinical trials, specialty lab services, companion and in vitro diagnostic strategies, and biomarker data management.

• Read: Clinical Trial Trends: Non-malignant Hematology

  Clinical Trials

  Clinical Trial Trends: Non-malignant Hematology

  Jan 13, ‘25 | 4 min read

  • 

    Jen Vance

  Discover
• Read: Gene Therapy Assays: Regulatory Compliance with Unified Immunogenicity

  Translational Research - Regulatory - Assays - Gene Therapies

  Gene Therapy Assays: Regulatory Compliance with Unified Immunogenicity

  Jan 07, ‘25 | 11 min read

  • 

  • Deborah P.

    Maham A.

  Discover
• Read: Top Clinical Research Organizations for Rare Diseases in 2025

  Clinical Trials - Rare Diseases

  Top Clinical Research Organizations for Rare Diseases in 2025

  Jan 03, ‘25 | 8 min read

  • 

    Rob Maiale

  Discover
• Read: Clinical Trial Trends: Late Phase Oncology

  Clinical Trials - Oncology

  Clinical Trial Trends: Late Phase Oncology

  Dec 12, ‘24 | 5 min read

  • 

    Natacha Grand

  Discover
• Read: Clinical Trial Trends: Antibody-Drug Conjugates

  Clinical Trials - Oncology

  Clinical Trial Trends: Antibody-Drug Conjugates

  Dec 10, ‘24 | 5 min read

  • 

    Natacha Grand

  Discover
• Read: The BIOSECURE Act’s Impact May Outlive the Bill Itself

  Manufacturing

  The BIOSECURE Act’s Impact May Outlive the Bill Itself

  Dec 10, ‘24 | 1 min read

  • 

    Anshul Mangal

  Discover
• Read: Clinical Trial Trends: Early Phase Rare Oncology 

  Clinical Trials - Oncology - Rare Diseases

  Clinical Trial Trends: Early Phase Rare Oncology 

  Dec 03, ‘24 | 5 min read

  • 

    Robert Bauer

  Discover
• Read: Custom FSP Models That Help Biotechs Scale Smarter

  Clinical Trials

  Custom FSP Models That Help Biotechs Scale Smarter

  Dec 01, ‘24 | 7 min read

  • 

    Nithiya Ananthakrishnan

  Discover
• Read: Chevron Deference: A New Era for Biotech

  Manufacturing

  Chevron Deference: A New Era for Biotech

  Nov 20, ‘24 | 1 min read

  • 

    Anshul Mangal

  Discover

Loading...

You've reach the end Back to top